Use of Monte Carlo Simulation to Design an Optimized Pharmacodynamic Dosing Strategy for Meropenem
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Reference31 articles.
1. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men;Craig;Clin Infect Dis,1998
2. Cost-effective approaches to the treatment of community acquired pneumonia in the era of resistance;Kuti;Pharmacoeconomics,2002
3. Economic benefit of a pharmacodynamic influenced meropenem dosing strategy;Kuti;Am J Health-Syst Pharm,2003
4. Once-daily dosing of aminoglycosides: review and recommendations for clinical practice;Freeman;J Antimicrob Chemother,1997
5. Continuous infusion of β-lactam antibiotics;Craig;Antimicrob Agents Chemother,1992
Cited by 173 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. In vitro activity, pharmacodynamic profile and dose optimization of biapenem against NDM and OXA-48-like carbapenemase-producing Klebsiella pneumoniae: A multicentre study in Thailand;Journal of Global Antimicrobial Resistance;2024-06
2. Population Pharmacokinetic Modeling of Unbound Meropenem in Patients Undergoing Continuous Renal Replacement Therapy: An Observational Cohort Study;Therapeutic Drug Monitoring;2024-05-14
3. In vitro and in vivo activities of KSP-1007, a broad-spectrum inhibitor of serine- and metallo-β-lactamases, in combination with meropenem against carbapenem-resistant Gram-negative bacteria;Antimicrobial Agents and Chemotherapy;2024-05-06
4. Meropenem-ANT3310, a unique β-lactam-β-lactamase inhibitor combination with expanded antibacterial spectrum against Gram-negative pathogens including carbapenem-resistant Acinetobacter baumannii;Antimicrobial Agents and Chemotherapy;2024-03-06
5. Relationship between Target Time above Minimum Inhibitory Concentration Achievement Rate of Meropenem Using Monte Carlo Simulation and In-Hospital Survival in Patients with Pseudomonas aeruginosa Bacteremia;Antibiotics;2024-02-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3